VERISCAL D 1.500 MG/400 IU CHEWABLE TABLETS
SpainIt is used to treat vitamin D deficiency in people who require calcium, and also as a vitamin D and calcium supplement in certain treatments for osteoporosis.
Frequently asked questions
How should I take Veriscal D?
Adults should take 1 to 2 chewable tablets daily, preferably after meals. It is important to chew the tablets thoroughly before swallowing and to drink a glass of water afterwards.
When should I not take this medication?
Do not take it if you are allergic to calcium, vitamin D, or any of its components; if you have kidney stones; if you have high calcium levels in your blood or urine; or if you have an allergy to peanuts or soy.
What side effects can Veriscal D cause?
It may cause elevated calcium levels in the blood or urine. Side effects such as constipation, gas, nausea, abdominal pain, or diarrhea may also occur.
Can I take other medications along with Veriscal D?
Some medications may interfere with its effect, such as certain antibiotics (tetracyclines), osteoporosis medications (bisphosphonates), diuretics, anticonvulsants, or corticosteroids. You should inform your doctor about any other drugs you are taking.
Should I be careful with food when taking it?
It is recommended not to take the medication within two hours after consuming foods high in oxalic acid (such as spinach or rhubarb) or phytic acid (such as whole grain bread or cereals).
What should I do if I take a dose greater than the indicated?
In case of overdose, you must consult your doctor or pharmacist immediately, as you may experience thirst, nausea, vomiting, or increased calcium levels.
Instructions for use
Package leaflet: Information for the user
Introduction
Package leaflet: information for the patient
Veriscal D 1,500 mg/400 IU chewable tablets
(calcium carbonate/colecalciferol)
Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.
- Keep this leaflet, as you may need to read it again.
- If you have any questions, ask your doctor, pharmacist or nurse.
- This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
- If you experience any adverse effects, consult your doctor, pharmacist or nurse, even if they are adverse effects not listed in this leaflet. See section 4.
Leaflet contents
- What Veriscal D is and what it is used for
- What you need to know before taking Veriscal D
- How to take Veriscal D
- Possible adverse effects
- How to store Veriscal D
- Contents of the pack and other information
1. What Veriscal D is and what it is used for
This medicine is a combination of calcium and vitamin D.
Veriscal D is indicated for the treatment of vitamin D deficiency states in patients who require calcium supplementation, as well as for vitamin D and calcium supplementation associated with certain osteoporosis treatments.
2. What you need to know before taking Veriscal D
Do not take Veriscal D
- if you are allergic to calcium, vitamin D, or any of the other ingredients of this medicine (listed in section 6).
- if you have kidney stones (renal calculi).
- if you have high levels of calcium in your blood or urine.
- this medicine contains soya oil. It should not be used if you are allergic to peanuts or soya.
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before starting to take Veriscal D
- during long-term treatment with this medicine; your doctor will monitor your urinary calcium levels and adjust your dose accordingly.
- if your kidneys do not function properly or you are prone to developing kidney stones.
- in elderly patients, regular monitoring of kidney function is recommended.
- if you have sarcoidosis (a disease causing inflammation of lymph nodes, lungs, liver, eyes, skin, and other tissues).
Other medicines and Veriscal D
Tell your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.
Certain medicines may interfere with this medicine; in such cases it may be necessary to adjust the dose, interrupt treatment with one of the medicines, or wait at least a few hours between administrations.
It is important that you inform your doctor if you are taking or have recently taken any of the following medicines:
- Cardiac glycosides (medicines for the heart).
- Tetracyclines (certain antibiotics); wait at least 3 hours between doses.
- Thiazide diuretics (medicines that increase excretion of water and sodium).
- Anticonvulsants (medicines used to treat seizures).
- Systemic corticosteroids (medicines used as anti-inflammatory agents in various diseases).
- Bisphosphonates and sodium fluoride (medicines used to treat osteoporosis); wait at least 3 hours between doses.
- Barbiturates (medicines that induce sleep) or phenytoin (a medicine used to treat epilepsy).
Taking Veriscal D with food, drinks, and alcohol
If you take this medicine together with foods or drinks containing oxalic acid (found in spinach and rhubarb) or phytic acid (found in wholemeal bread and whole grains), interactions may occur. Therefore, it is recommended not to take this medicine within two hours after consuming foods high in oxalic acid or phytic acid.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you might be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
Taking medicines during pregnancy may be harmful to the embryo or fetus.
During pregnancy and breastfeeding, daily intake should not exceed 1,500 mg of calcium and 600 IU of vitamin D3.
In pregnant women, vitamin D overdosage should be avoided, as prolonged high levels of calcium in the blood may cause fetal abnormalities.
Driving and using machines
No effects on the ability to drive or operate machinery have been observed.
Veriscal D contains sorbitol, aspartame, lactose, sucrose, and sodium
This medicine contains 565.25 mg of sorbitol per tablet, equivalent to 232.04 mg/g.
Sorbitol is a source of fructose. If your doctor has informed you (or your child) that you have an intolerance to certain sugars, or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which the body cannot break down fructose, consult your doctor (or your child’s doctor) before taking this medicine.
This medicine contains 5.00 mg of aspartame per tablet, equivalent to 2.05 mg/g.
Aspartame contains a source of phenylalanine, which may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body cannot eliminate it properly.
This medicine contains lactose. If your doctor has informed you of an intolerance to certain sugars, consult your doctor before taking this medicine.
This medicine contains sucrose. If your doctor has informed you of an intolerance to certain sugars, consult your doctor before taking this medicine. It may cause dental caries.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; therefore, it is essentially “sodium-free.”
Interactions with diagnostic tests
If you are scheduled for any diagnostic tests (blood or urine analyses, etc.), inform your doctor that you are being treated with Veriscal D, as it may alter test results.
3. How to take Veriscal D
Follow exactly the administration instructions for this medicine as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Remember to take your medicine. The recommended dose is:
Adults: 1-2 chewable tablets per day, preferably after meals.
Use in children and adolescents
Consult your doctor to individualize the dose.
To properly administer the medicine, chew the tablets well before swallowing, then drink a glass of water.
If you think that the effect of this medicine is too strong or too weak, inform your doctor or pharmacist.
If you take more Veriscal D than you should
In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service at: 91 562.04.20, indicating the medicine and the amount ingested.
If you have taken more Veriscal D than you should, contact your doctor or pharmacist immediately.
Deliberate or accidental intoxication with chewable preparations is unlikely.
In case of overdose, you may experience thirst, increased calcium levels in blood, increased calcium levels in urine, anorexia, nausea, vomiting, abnormal excretion of large amounts of urine, and calcium deposits in soft tissues.
If you forget to take Veriscal D
Do not take a double dose to make up for missed doses. Simply take the missed dose when you remember, and then take the following doses at the recommended intervals (12 – 24 hours).
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.
The following adverse effects have been observed:
Uncommon (may affect up to 1 in 100 people): hypercalcaemia (high levels of calcium in the blood) and hypercalciuria (high levels of calcium in the urine).
Rare (may affect up to 1 in 1,000 people): constipation, flatulence, nausea, abdominal pain, and diarrhoea.
Occasionally, mild gastrointestinal disturbances. Veriscal D may promote the formation of kidney stones in patients with impaired renal function.
If you consider any of the adverse effects you experience to be severe, or if you notice any adverse effects not listed in this leaflet, inform your doctor or pharmacist.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Veriscal D
Keep this medicine out of the sight and reach of children.
Store in the original packaging to protect from moisture.
Do not use this medicine after the expiry date stated on the packaging after “EXP”. The expiry date refers to the last day of the month indicated.
Medicines must not be disposed of via wastewater or household waste. Dispose of unused medicines and their containers at the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of medicines and containers you no longer need. This will help protect the environment.
6. Contents of the pack and other information
Composition of Veriscal D
The active substances are calcium carbonate and colecalciferol (vitamin D3).
Each tablet contains 1,500 mg of calcium carbonate (equivalent to 600 mg of calcium) and 400 IU of colecalciferol (vitamin D3) (equivalent to 0.01 mg).
The other components (excipients) are: sorbitol (E420), maltodextrin, monohydrate lactose, magnesium stearate, sodium croscarmellose, anise flavour, mint flavour, molasses flavour, aspartame (E951), sodium saccharin, sucrose, gelatin, corn starch, partially hydrogenated soybean oil, all-rac-α-tocopherol and silicon dioxide.
Appearance of the product and contents of the pack
Veriscal D is presented as white or almost white chewable tablets, marked with a "D" on one side.
Each pack contains 60 chewable tablets.
Marketing Authorization Holder
Laboratorios Farmacéuticos VALOMED, S.A.
C/ San Rafael, 3
28108 Alcobendas, Madrid
Spain
Manufacturer
ITALFARMACO S.p.A.
Viale Fulvio Testi, 330
20126 Milan
Italy
For further information about this medicinal product, you may contact the local representative of the Marketing Authorization Holder
Italfarmaco, S.A.
C/ San Rafael, 3
28108 Alcobendas, Madrid
Spain
Date of the most recent revision of this leaflet: August 2024
Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es).
Similar drugs
The original data is available in the language of the country of manufacture.
Data source: Online Medicines Information Centre (CIMA) — AEMPS
Data last verified: September 21, 2026